国产一区二区三区视频精品-国产一区二区三区视频在线观看-国产一区二区三区四区五区-国产一区二区三区四区五区精品-国产一区二区三区无码免费-国产一区二区三区在线

美國(guó)BioReliance 　
　BioReliance總部設(shè)在馬里蘭州，其主要向制藥、生物制藥、診斷和其他生命科學(xué)領(lǐng)域的客戶提供生物學(xué)、專門毒理學(xué)和動(dòng)物健康測(cè)試。公司2010年全年收入約1.1億美元，預(yù)計(jì)2011年有兩位數(shù)增長(zhǎng)。

BioReliance provides testing and manufacturing services to pharmaceutical and biopharmaceutical companies that span the product cycle from early pre-clinical development to licensed production.

Our goal is to advance the development and delivery of healthcare and consumer products by providing the highest quality testing, development and manufacturing services in partnership with clients worldwide.

BioReliance has provided outsourced services to thousands of customers from most healthcare disciplines, including nearly all of the largest pharmaceutical, biopharmaceutical, and chemical companies in the world. BioReliance is the largest provider of safety testing services focused on the rapidly growing biologics sector of the pharmaceutical and biotechnology industries.

For established biotechnology and pharmaceutical companies, outsourcing to BioReliance streamlines product development and reduces time to market. The Company also enables emerging and clinical stage companies who may lack the staff, expertise and financial resources to conduct many aspects of product development in-house.

Unless otherwise stated or requested, all studies conducted by BioReliance are performed in compliance with the requirements of the UK and German GLP Regulations, the US FDA Good Laboratory Practice Regulations (21 CFR 58), the Japanese GLP Standard and the OECD Principles of Good Laboratory Practice. BioReliance is fully accredited for GLP. To date, many products licensed by the FDA, EMEA and other international agencies have been tested and validated by BioReliance.

All of our studies are conducted under strict confidentiality.